On January 27, 2023, the Family Research Council, joined by thirteen other pro-life organizations, issued a letter to Walmart’s leadership, urging the retailer not to pursue certification for dispensing chemical abortion drugs.
This initiative aimed to prevent major corporations from facilitating abortions, citing significant health risks to women and ethical objections rooted in pro-life principles.
The move reflected ongoing conservative efforts to safeguard human dignity and family values by limiting access to abortion-inducing medications through mainstream channels.